| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.019 | 8.546 | - | 18.458 | 9.949 | 10.186 | 9.677 | 21.275 | 27.053 | 31.117 |
| Total Income - EUR | 1.106 | 8.546 | - | 18.458 | 9.949 | 10.186 | 9.677 | 21.275 | 30.326 | 31.327 |
| Total Expenses - EUR | 790 | 8.041 | - | 4.395 | 5.400 | 8.396 | 7.709 | 7.612 | 13.062 | 27.061 |
| Gross Profit/Loss - EUR | 316 | 505 | - | 14.063 | 4.549 | 1.789 | 1.968 | 13.664 | 17.264 | 4.266 |
| Net Profit/Loss - EUR | 289 | 255 | - | 13.512 | 4.370 | 1.687 | 1.871 | 13.025 | 14.502 | 3.583 |
| Employees | 0 | 0 | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Profiland Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 0 | 0 | 0 | 0 | 9.586 | 16.437 | 17.412 |
| Current Assets | 1.054 | 2.316 | - | 16.446 | 21.649 | 24.262 | 24.346 | 29.444 | 44.671 | 240.052 |
| Inventories | 0 | 2.076 | - | 3.216 | 3.154 | 3.654 | 3.719 | 6.046 | 3.476 | 695 |
| Receivables | 2 | 0 | - | 116 | 615 | 1.130 | 1.105 | 1.108 | 1.105 | 238.655 |
| Cash | 1.052 | 240 | - | 13.114 | 17.880 | 19.478 | 19.523 | 22.289 | 40.090 | 703 |
| Shareholders Funds | 689 | 934 | - | 16.307 | 20.361 | 21.662 | 23.053 | 36.150 | 50.542 | 17.875 |
| Social Capital | 112 | 111 | - | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 365 | 1.382 | - | 139 | 1.288 | 2.599 | 1.293 | 2.879 | 10.565 | 1.834 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 237.755 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Profiland Med Srl